EMEA (Europe, Middle East and Africa) Oncology Adjuvants Market Report 2017

August 2017 | 103 pages | ID: EF42DA1BF8CEN
QYResearch

Abstracts

In this report, the EMEA Oncology Adjuvants market is valued at USD XX million in 2016 and is expected to reach USD XX million by the end of 2022, growing at a CAGR of XX% between 2016 and 2022.

Geographically, this report split EMEA into Europe, the Middle East and Africa, With sales (K Units), revenue (Million USD), market share and growth rate of Oncology Adjuvants for these regions, from 2012 to 2022 (forecast)

• Europe: Germany, France, UK, Russia, Italy and Benelux;
• Middle East: Saudi Arabia, Israel, UAE and Iran;
• Africa: South Africa, Nigeria, Egypt and Algeria.

EMEA Oncology Adjuvants market competition by top manufacturers/players, with Oncology Adjuvants sales volume (K Units), price (USD/Unit), revenue (Million USD) and market share for each manufacturer/player; the top players including

• Amgen
• Sanofi
• Pfizer
• Eli Lilly
• BMS
• AstraZeneca
• Biogen

On the basis of product, this report displays the sales volume (K Units), revenue (Million USD), product price (USD/Unit), market share and growth rate of each type, primarily split into

• Chemotherapy
• Hormone Therapy
• Immunotherapy
• Targeted Therapy
• Radiotherapy
• Others

On the basis on the end users/applications, this report focuses on the status and outlook for major applications/end users, sales volume (K Units), market share and growth rate of Oncology Adjuvants for each application, including

• Breast Cancer
• Glioblastoma
• Lung Cancer
• Colorectal Cancer
• Ovarian Cancer
• Sarcoma
• Prostate Cancer
• Others

Contents

EMEA (Europe, Middle East and Africa) Oncology Adjuvants Market Report 2017

1 ONCOLOGY ADJUVANTS OVERVIEW

1.1 Product Overview and Scope of Oncology Adjuvants
1.2 Classification of Oncology Adjuvants
  1.2.1 EMEA Oncology Adjuvants Market Size (Sales) Comparison by Type (2012-2022)
  1.2.2 EMEA Oncology Adjuvants Market Size (Sales) Market Share by Type (Product Category) in 2016
  1.2.3 Chemotherapy
  1.2.4 Hormone Therapy
  1.2.5 Immunotherapy
  1.2.6 Targeted Therapy
  1.2.7 Radiotherapy
  1.2.8 Others
1.3 EMEA Oncology Adjuvants Market by Application/End Users
  1.3.1 EMEA Oncology Adjuvants Sales (Volume) and Market Share Comparison by Application (2012-2022
  1.3.2 Breast Cancer
  1.3.3 Glioblastoma
  1.3.4 Lung Cancer
  1.3.5 Colorectal Cancer
  1.3.6 Ovarian Cancer
  1.3.7 Sarcoma
  1.3.8 Prostate Cancer
  1.3.9 Others
1.4 EMEA Oncology Adjuvants Market by Region
  1.4.1 EMEA Oncology Adjuvants Market Size (Value) Comparison by Region (2012-2022)
  1.4.2 Europe Status and Prospect (2012-2022)
  1.4.3 Middle East Status and Prospect (2012-2022)
  1.4.4 Africa Status and Prospect (2012-2022)
1.5 EMEA Market Size (Value and Volume) of Oncology Adjuvants (2012-2022)
  1.5.1 EMEA Oncology Adjuvants Sales and Growth Rate (2012-2022)
  1.5.2 EMEA Oncology Adjuvants Revenue and Growth Rate (2012-2022)

2 EMEA ONCOLOGY ADJUVANTS COMPETITION BY MANUFACTURERS/PLAYERS/SUPPLIERS, REGION, TYPE AND APPLICATION

2.1 EMEA Oncology Adjuvants Market Competition by Players/Manufacturers
  2.1.1 EMEA Oncology Adjuvants Sales Volume and Market Share of Major Players (2012-2017)
  2.1.2 EMEA Oncology Adjuvants Revenue and Share by Players (2012-2017)
  2.1.3 EMEA Oncology Adjuvants Sale Price by Players (2012-2017)
2.2 EMEA Oncology Adjuvants (Volume and Value) by Type/Product Category
  2.2.1 EMEA Oncology Adjuvants Sales and Market Share by Type (2012-2017)
  2.2.2 EMEA Oncology Adjuvants Revenue and Market Share by Type (2012-2017)
  2.2.3 EMEA Oncology Adjuvants Sale Price by Type (2012-2017)
2.3 EMEA Oncology Adjuvants (Volume) by Application
2.4 EMEA Oncology Adjuvants (Volume and Value) by Region
  2.4.1 EMEA Oncology Adjuvants Sales and Market Share by Region (2012-2017)
  2.4.2 EMEA Oncology Adjuvants Revenue and Market Share by Region (2012-2017)
  2.4.3 EMEA Oncology Adjuvants Sales Price by Region (2012-2017)

3 EUROPE ONCOLOGY ADJUVANTS (VOLUME, VALUE AND SALES PRICE), BY PLAYERS, COUNTRIES, TYPE AND APPLICATION

3.1 Europe Oncology Adjuvants Sales and Value (2012-2017)
  3.1.1 Europe Oncology Adjuvants Sales Volume and Growth Rate (2012-2017)
  3.1.2 Europe Oncology Adjuvants Revenue and Growth Rate (2012-2017)
3.2 Europe Oncology Adjuvants Sales and Market Share by Type
3.3 Europe Oncology Adjuvants Sales and Market Share by Application
3.4 Europe Oncology Adjuvants Sales Volume and Value (Revenue) by Countries
  3.4.1 Europe Oncology Adjuvants Sales Volume by Countries (2012-2017)
  3.4.2 Europe Oncology Adjuvants Revenue by Countries (2012-2017)
  3.4.3 Germany Oncology Adjuvants Sales and Growth Rate (2012-2017)
  3.4.4 France Oncology Adjuvants Sales and Growth Rate (2012-2017)
  3.4.5 UK Oncology Adjuvants Sales and Growth Rate (2012-2017)
  3.4.6 Russia Oncology Adjuvants Sales and Growth Rate (2012-2017)
  3.4.7 Italy Oncology Adjuvants Sales and Growth Rate (2012-2017)
  3.4.8 Benelux Oncology Adjuvants Sales and Growth Rate (2012-2017)

4 MIDDLE EAST ONCOLOGY ADJUVANTS (VOLUME, VALUE AND SALES PRICE), BY REGION, TYPE AND APPLICATION

4.1 Middle East Oncology Adjuvants Sales and Value (2012-2017)
  4.1.1 Middle East Oncology Adjuvants Sales Volume and Growth Rate (2012-2017)
  4.1.2 Middle East Oncology Adjuvants Revenue and Growth Rate (2012-2017)
4.2 Middle East Oncology Adjuvants Sales and Market Share by Type
4.3 Middle East Oncology Adjuvants Sales and Market Share by Application
4.4 Middle East Oncology Adjuvants Sales Volume and Value (Revenue) by Countries
  4.4.1 Middle East Oncology Adjuvants Sales Volume by Countries (2012-2017)
  4.4.2 Middle East Oncology Adjuvants Revenue by Countries (2012-2017)
  4.4.3 Saudi Arabia Oncology Adjuvants Sales and Growth Rate (2012-2017)
  4.4.4 Israel Oncology Adjuvants Sales and Growth Rate (2012-2017)
  4.4.5 UAE Oncology Adjuvants Sales and Growth Rate (2012-2017)
  4.4.6 Iran Oncology Adjuvants Sales and Growth Rate (2012-2017)

5 AFRICA ONCOLOGY ADJUVANTS (VOLUME, VALUE AND SALES PRICE) BY PLAYERS, COUNTRIES, TYPE AND APPLICATION

5.1 Africa Oncology Adjuvants Sales and Value (2012-2017)
  5.1.1 Africa Oncology Adjuvants Sales Volume and Growth Rate (2012-2017)
  5.1.2 Africa Oncology Adjuvants Revenue and Growth Rate (2012-2017)
5.2 Africa Oncology Adjuvants Sales and Market Share by Type
5.3 Africa Oncology Adjuvants Sales and Market Share by Application
5.4 Africa Oncology Adjuvants Sales Volume and Value (Revenue) by Countries
  5.4.1 Africa Oncology Adjuvants Sales Volume by Countries (2012-2017)
  5.4.2 Africa Oncology Adjuvants Revenue by Countries (2012-2017)
  5.4.3 South Africa Oncology Adjuvants Sales and Growth Rate (2012-2017)
  5.4.4 Nigeria Oncology Adjuvants Sales and Growth Rate (2012-2017)
  5.4.5 Egypt Oncology Adjuvants Sales and Growth Rate (2012-2017)
  5.4.6 Algeria Oncology Adjuvants Sales and Growth Rate (2012-2017)

6 EMEA ONCOLOGY ADJUVANTS MANUFACTURERS/PLAYERS PROFILES AND SALES DATA

6.1 Amgen
  6.1.1 Company Basic Information, Manufacturing Base and Competitors
  6.1.2 Oncology Adjuvants Product Type, Application and Specification
    6.1.2.1 Product A
    6.1.2.2 Product B
  6.1.3 Amgen Oncology Adjuvants Sales, Revenue, Price and Gross Margin (2012-2017)
  6.1.4 Main Business/Business Overview
6.2 Sanofi
  6.2.1 Company Basic Information, Manufacturing Base and Competitors
  6.2.2 Oncology Adjuvants Product Type, Application and Specification
    6.2.2.1 Product A
    6.2.2.2 Product B
  6.2.3 Sanofi Oncology Adjuvants Sales, Revenue, Price and Gross Margin (2012-2017)
  6.2.4 Main Business/Business Overview
6.3 Pfizer
  6.3.1 Company Basic Information, Manufacturing Base and Competitors
  6.3.2 Oncology Adjuvants Product Type, Application and Specification
    6.3.2.1 Product A
    6.3.2.2 Product B
  6.3.3 Pfizer Oncology Adjuvants Sales, Revenue, Price and Gross Margin (2012-2017)
  6.3.4 Main Business/Business Overview
6.4 Eli Lilly
  6.4.1 Company Basic Information, Manufacturing Base and Competitors
  6.4.2 Oncology Adjuvants Product Type, Application and Specification
    6.4.2.1 Product A
    6.4.2.2 Product B
  6.4.3 Eli Lilly Oncology Adjuvants Sales, Revenue, Price and Gross Margin (2012-2017)
  6.4.4 Main Business/Business Overview
6.5 BMS
  6.5.1 Company Basic Information, Manufacturing Base and Competitors
  6.5.2 Oncology Adjuvants Product Type, Application and Specification
    6.5.2.1 Product A
    6.5.2.2 Product B
  6.5.3 BMS Oncology Adjuvants Sales, Revenue, Price and Gross Margin (2012-2017)
  6.5.4 Main Business/Business Overview
6.6 AstraZeneca
  6.6.1 Company Basic Information, Manufacturing Base and Competitors
  6.6.2 Oncology Adjuvants Product Type, Application and Specification
    6.6.2.1 Product A
    6.6.2.2 Product B
  6.6.3 AstraZeneca Oncology Adjuvants Sales, Revenue, Price and Gross Margin (2012-2017)
  6.6.4 Main Business/Business Overview
6.7 Biogen
  6.7.1 Company Basic Information, Manufacturing Base and Competitors
  6.7.2 Oncology Adjuvants Product Type, Application and Specification
    6.7.2.1 Product A
    6.7.2.2 Product B
  6.7.3 Biogen Oncology Adjuvants Sales, Revenue, Price and Gross Margin (2012-2017)
  6.7.4 Main Business/Business Overview

7 ONCOLOGY ADJUVANTS MANUFACTURING COST ANALYSIS

7.1 Oncology Adjuvants Key Raw Materials Analysis
  7.1.1 Key Raw Materials
  7.1.2 Price Trend of Key Raw Materials
  7.1.3 Key Suppliers of Raw Materials
  7.1.4 Market Concentration Rate of Raw Materials
7.2 Proportion of Manufacturing Cost Structure
  7.2.1 Raw Materials
  7.2.2 Labor Cost
  7.2.3 Manufacturing Expenses
7.3 Manufacturing Process Analysis of Oncology Adjuvants

8 INDUSTRIAL CHAIN, SOURCING STRATEGY AND DOWNSTREAM BUYERS

8.1 Oncology Adjuvants Industrial Chain Analysis
8.2 Upstream Raw Materials Sourcing
8.3 Raw Materials Sources of Oncology Adjuvants Major Manufacturers in 2016
8.4 Downstream Buyers

9 MARKETING STRATEGY ANALYSIS, DISTRIBUTORS/TRADERS

9.1 Marketing Channel
  9.1.1 Direct Marketing
  9.1.2 Indirect Marketing
  9.1.3 Marketing Channel Development Trend
9.2 Market Positioning
  9.2.1 Pricing Strategy
  9.2.2 Brand Strategy
  9.2.3 Target Client
9.3 Distributors/Traders List

10 MARKET EFFECT FACTORS ANALYSIS

10.1 Technology Progress/Risk
  10.1.1 Substitutes Threat
  10.1.2 Technology Progress in Related Industry
10.2 Consumer Needs/Customer Preference Change
10.3 Economic/Political Environmental Change

11 EMEA ONCOLOGY ADJUVANTS MARKET FORECAST (2017-2022)

11.1 EMEA Oncology Adjuvants Sales, Revenue and Price Forecast (2017-2022)
  11.1.1 EMEA Oncology Adjuvants Sales and Growth Rate Forecast (2017-2022)
  11.1.2 EMEA Oncology Adjuvants Revenue and Growth Rate Forecast (2017-2022)
  11.1.3 EMEA Oncology Adjuvants Price and Trend Forecast (2017-2022)
11.2 EMEA Oncology Adjuvants Sales, Revenue and Growth Rate Forecast by Region (2017-2022)
11.3 Europe Oncology Adjuvants Sales, Revenue and Growth Rate Forecast by Region (2017-2022)
11.4 Middle Eastt Oncology Adjuvants Sales, Revenue and Growth Rate Forecast by Region (2017-2022)
11.5 Africa Oncology Adjuvants Sales, Revenue and Growth Rate Forecast by Region (2017-2022)
11.6 EMEA Oncology Adjuvants Sales Forecast by Type (2017-2022)
11.7 EMEA Oncology Adjuvants Sales Forecast by Application (2017-2022)

12 RESEARCH FINDINGS AND CONCLUSION

13 APPENDIX

13.1 Methodology/Research Approach
  13.1.1 Research Programs/Design
  13.1.2 Market Size Estimation
  13.1.3 Market Breakdown and Data Triangulation
13.2 Data Source
  13.2.1 Secondary Sources
  13.2.2 Primary Sources
13.3 Disclaimer


The report requires updating with new data and is sent in 2-3 business days after order is placed.

List Of Tables

LIST OF TABLES AND FIGURES

Figure Product Picture of Oncology Adjuvants
Figure EMEA Oncology Adjuvants Sales Volume (K Units) by Type (2012-2022)
Figure EMEA Oncology Adjuvants Sales Volume Market Share by Type (Product Category) in 2016
Figure Chemotherapy Product Picture
Figure Hormone Therapy Product Picture
Figure Immunotherapy Product Picture
Figure Targeted Therapy Product Picture
Figure Radiotherapy Product Picture
Figure Others Product Picture
Figure EMEA Oncology Adjuvants Sales Volume (K Units) by Application (2012-2022)
Figure EMEA Sales Market Share of Oncology Adjuvants by Application in 2016
Figure Breast Cancer Examples
Figure Glioblastoma Examples
Figure Lung Cancer Examples
Figure Colorectal Cancer Examples
Figure Ovarian Cancer Examples
Figure Sarcoma Examples
Figure Prostate Cancer Examples
Figure Others Examples
Figure EMEA Oncology Adjuvants Market Size (Million USD) by Region (2012-2022)
Figure Europe Oncology Adjuvants Revenue (Million USD) and Growth Rate (2012-2022)
Figure Europe Oncology Adjuvants Revenue (Million USD) Status and Forecast by Countries
Figure Middle East Oncology Adjuvants Revenue (Million USD) and Growth Rate (2012-2022)
Figure Middle East Oncology Adjuvants Revenue (Million USD) Status and Forecast by Countries
Figure Africa Oncology Adjuvants Revenue (Million USD) and Growth Rate (2012-2022)
Figure Africa Oncology Adjuvants Revenue (Million USD) Status and Forecast by Countries
Figure EMEA Oncology Adjuvants Sales Volume and Growth Rate (2012-2022)
Figure EMEA Oncology Adjuvants Revenue (Million USD) and Growth Rate (2012-2022)
Figure EMEA Oncology Adjuvants Market Major Players Product Sales Volume (K Units) (2012-2017)
Table EMEA Oncology Adjuvants Sales Volume (K Units) of Major Players (2012-2017)
Table EMEA Oncology Adjuvants Sales Share by Players (2012-2017)
Figure 2016 Oncology Adjuvants Sales Share by Players
Figure 2017 Oncology Adjuvants Sales Share by Players
Figure EMEA Oncology Adjuvants Market Major Players Product Revenue (Million USD) (2012-2017)
Table EMEA Oncology Adjuvants Revenue (Million USD) by Players (2012-2017)
Table EMEA Oncology Adjuvants Revenue Share by Players (2012-2017)
Table 2016 EMEA Oncology Adjuvants Revenue Share by Players
Table 2017 EMEA Oncology Adjuvants Revenue Share by Players
Table EMEA Oncology Adjuvants Sale Price (USD/Unit) by Players (2012-2017)
Table EMEA Oncology Adjuvants Sales (K Units) and Market Share by Type (2012-2017)
Table EMEA Oncology Adjuvants Sales Share by Type (2012-2017)
Figure Sales Market Share of Oncology Adjuvants by Type (2012-2017)
Figure EMEA Oncology Adjuvants Sales Market Share by Type (2012-2017)
Table EMEA Oncology Adjuvants Revenue (Million USD) and Market Share by Type (2012-2017)
Table EMEA Oncology Adjuvants Revenue Share by Type (2012-2017)
Figure Revenue Market Share of Oncology Adjuvants by Type in 2016
Table EMEA Oncology Adjuvants Sale Price (USD/Unit) by Type (2012-2017)
Table EMEA Oncology Adjuvants Sales (K Units) and Market Share by Application (2012-2017)
Table EMEA Oncology Adjuvants Sales Share by Application (2012-2017)
Figure Sales Market Share of Oncology Adjuvants by Application (2012-2017)
Figure EMEA Oncology Adjuvants Sales Market Share by Application in 2016
Table EMEA Oncology Adjuvants Sales (K Units) and Market Share by Region (2012-2017)
Table EMEA Oncology Adjuvants Sales Share by Region (2012-2017)
Figure Sales Market Share of Oncology Adjuvants by Region (2012-2017)
Figure EMEA Oncology Adjuvants Sales Market Share in 2016
Table EMEA Oncology Adjuvants Revenue (Million USD) and Market Share by Region (2012-2017)
Table EMEA Oncology Adjuvants Revenue Share by Region (2012-2017)
Figure Revenue Market Share of Oncology Adjuvants by Region (2012-2017)
Figure EMEA Oncology Adjuvants Revenue Market Share Regions in 2016
Table EMEA Oncology Adjuvants Sales Price (USD/Unit) by Region (2012-2017)
Figure Europe Oncology Adjuvants Sales (K Units) and Growth Rate (2012-2017)
Figure Europe Oncology Adjuvants Revenue and Growth Rate (2012-2017)
Table Europe Oncology Adjuvants Sales (K Units) by Type (2012-2017)
Table Europe Oncology Adjuvants Market Share by Type (2012-2017)
Figure Europe Oncology Adjuvants Market Share by Type in 2016
Table Europe Oncology Adjuvants Sales (K Units) by Application (2012-2017)
Table Europe Oncology Adjuvants Market Share by Application (2012-2017)
Figure Europe Oncology Adjuvants Market Share by Application in 2016
Table Europe Oncology Adjuvants Sales (K Units) by Countries (2012-2017)
Table Europe Oncology Adjuvants Sales Market Share by Countries (2012-2017)
Figure Europe Oncology Adjuvants Sales Market Share by Countries (2012-2017)
Figure Europe Oncology Adjuvants Sales Market Share by Countries in 2016
Table Europe Oncology Adjuvants Revenue (Million USD) by Countries (2012-2017)
Table Europe Oncology Adjuvants Revenue Market Share by Countries (2012-2017)
Figure Europe Oncology Adjuvants Revenue Market Share by Countries (2012-2017)
Figure Europe Oncology Adjuvants Revenue Market Share by Countries in 2016
Figure Germany Oncology Adjuvants Sales (K Units) and Growth Rate (2012-2017)
Figure France Oncology Adjuvants Sales (K Units) and Growth Rate (2012-2017)
Figure UK Oncology Adjuvants Sales (K Units) and Growth Rate (2012-2017)
Figure Russia Oncology Adjuvants Sales (K Units) and Growth Rate (2012-2017)
Figure Italy Oncology Adjuvants Sales (K Units) and Growth Rate (2012-2017)
Figure Benelux Oncology Adjuvants Sales (K Units) and Growth Rate (2012-2017)
Figure Middle East Oncology Adjuvants Sales (K Units) and Growth Rate (2012-2017)
Figure Middle East Oncology Adjuvants Revenue (Million USD) and Growth Rate (2012-2017)
Table Middle East Oncology Adjuvants Sales (K Units) by Type (2012-2017)
Table Middle East Oncology Adjuvants Market Share by Type (2012-2017)
Figure Middle East Oncology Adjuvants Market Share by Type (2012-2017)
Table Middle East Oncology Adjuvants Sales (K Units) by Applications (2012-2017)
Table Middle East Oncology Adjuvants Market Share by Applications (2012-2017)
Figure Middle East Oncology Adjuvants Sales Market Share by Application in 2016
Table Middle East Oncology Adjuvants Sales Volume (K Units) by Countries (2012-2017)
Table Middle East Oncology Adjuvants Sales Volume Market Share by Countries (2012-2017)
Figure Middle East Oncology Adjuvants Sales Volume Market Share by Countries in 2016
Table Middle East Oncology Adjuvants Revenue (Million USD) by Countries (2012-2017)
Table Middle East Oncology Adjuvants Revenue Market Share by Countries (2012-2017)
Figure Middle East Oncology Adjuvants Revenue Market Share by Countries (2012-2017)
Figure Middle East Oncology Adjuvants Revenue Market Share by Countries in 2016
Figure Saudi Arabia Oncology Adjuvants Sales (K Units) and Growth Rate (2012-2017)
Figure Israel Oncology Adjuvants Sales (K Units) and Growth Rate (2012-2017)
Figure UAE Oncology Adjuvants Sales (K Units) and Growth Rate (2012-2017)
Figure Iran Oncology Adjuvants Sales (K Units) and Growth Rate (2012-2017)
Figure Africa Oncology Adjuvants Sales (K Units) and Growth Rate (2012-2017)
Figure Africa Oncology Adjuvants Revenue (Million USD) and Growth Rate (2012-2017)
Table Africa Oncology Adjuvants Sales (K Units) by Type (2012-2017)
Table Africa Oncology Adjuvants Sales Market Share by Type (2012-2017)
Figure Africa Oncology Adjuvants Sales Market Share by Type (2012-2017)
Figure Africa Oncology Adjuvants Sales Market Share by Type in 2016
Table Africa Oncology Adjuvants Sales (K Units) by Application (2012-2017)
Table Africa Oncology Adjuvants Sales Market Share by Application (2012-2017)
Figure Africa Oncology Adjuvants Sales Market Share by Application (2012-2017)
Table Africa Oncology Adjuvants Sales Volume (K Units) by Countries (2012-2017)
Table Africa Oncology Adjuvants Sales Market Share by Countries (2012-2017)
Figure Africa Oncology Adjuvants Sales Market Share by Countries (2012-2017)
Figure Africa Oncology Adjuvants Sales Market Share by Countries in 2016
Table Africa Oncology Adjuvants Revenue (Million USD) by Countries (2012-2017)
Table Africa Oncology Adjuvants Revenue Market Share by Countries (2012-2017)
Figure Africa Oncology Adjuvants Revenue Market Share by Countries (2012-2017)
Figure Africa Oncology Adjuvants Revenue Market Share by Countries in 2016
Figure South Africa Oncology Adjuvants Sales (K Units) and Growth Rate (2012-2017)
Figure Nigeria Oncology Adjuvants Sales (K Units) and Growth Rate (2012-2017)
Figure Egypt Oncology Adjuvants Sales (K Units) and Growth Rate (2012-2017)
Figure Algeria Oncology Adjuvants Sales (K Units) and Growth Rate (2012-2017)
Table Amgen Oncology Adjuvants Basic Information List
Table Amgen Oncology Adjuvants Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2012-2017)
Figure Amgen Oncology Adjuvants Sales (K Units) and Growth Rate (2012-2017)
Figure Amgen Oncology Adjuvants Sales Market Share in EMEA (2012-2017)
Figure Amgen Oncology Adjuvants Revenue Market Share in EMEA (2012-2017)
Table Sanofi Oncology Adjuvants Basic Information List
Table Sanofi Oncology Adjuvants Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2012-2017)
Figure Sanofi Oncology Adjuvants Sales (K Units) and Growth Rate (2012-2017)
Figure Sanofi Oncology Adjuvants Sales Market Share in EMEA (2012-2017)
Figure Sanofi Oncology Adjuvants Revenue Market Share in EMEA (2012-2017)
Table Pfizer Oncology Adjuvants Basic Information List
Table Pfizer Oncology Adjuvants Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2012-2017)
Figure Pfizer Oncology Adjuvants Sales (K Units) and Growth Rate (2012-2017)
Figure Pfizer Oncology Adjuvants Sales Market Share in EMEA (2012-2017)
Figure Pfizer Oncology Adjuvants Revenue Market Share in EMEA (2012-2017)
Table Eli Lilly Oncology Adjuvants Basic Information List
Table Eli Lilly Oncology Adjuvants Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2012-2017)
Figure Eli Lilly Oncology Adjuvants Sales (K Units) and Growth Rate (2012-2017)
Figure Eli Lilly Oncology Adjuvants Sales Market Share in EMEA (2012-2017)
Figure Eli Lilly Oncology Adjuvants Revenue Market Share in EMEA (2012-2017)
Table BMS Oncology Adjuvants Basic Information List
Table BMS Oncology Adjuvants Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2012-2017)
Figure BMS Oncology Adjuvants Sales (K Units) and Growth Rate (2012-2017)
Figure BMS Oncology Adjuvants Sales Market Share in EMEA (2012-2017)
Figure BMS Oncology Adjuvants Revenue Market Share in EMEA (2012-2017)
Table AstraZeneca Oncology Adjuvants Basic Information List
Table AstraZeneca Oncology Adjuvants Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2012-2017)
Figure AstraZeneca Oncology Adjuvants Sales (K Units) and Growth Rate (2012-2017)
Figure AstraZeneca Oncology Adjuvants Sales Market Share in EMEA (2012-2017)
Figure AstraZeneca Oncology Adjuvants Revenue Market Share in EMEA (2012-2017)
Table Biogen Oncology Adjuvants Basic Information List
Table Biogen Oncology Adjuvants Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2012-2017)
Figure Biogen Oncology Adjuvants Sales (K Units) and Growth Rate (2012-2017)
Figure Biogen Oncology Adjuvants Sales Market Share in EMEA (2012-2017)
Figure Biogen Oncology Adjuvants Revenue Market Share in EMEA (2012-2017)
Table Production Base and Market Concentration Rate of Raw Material
Figure Price Trend of Key Raw Materials
Table Key Suppliers of Raw Materials
Figure Manufacturing Cost Structure of Oncology Adjuvants
Figure Manufacturing Process Analysis of Oncology Adjuvants
Figure Oncology Adjuvants Industrial Chain Analysis
Table Raw Materials Sources of Oncology Adjuvants Major Manufacturers in 2016
Table Major Buyers of Oncology Adjuvants
Table Distributors/Traders List
Figure EMEA Oncology Adjuvants Sales (K Units) and Growth Rate Forecast (2017-2022)
Figure EMEA Oncology Adjuvants Revenue and Growth Rate Forecast (2017-2022)
Figure EMEA Oncology Adjuvants Price (USD/Unit) and Trend Forecast (2017-2022)
Table EMEA Oncology Adjuvants Sales (K Units) Forecast by Region (2017-2022)
Figure EMEA Oncology Adjuvants Sales Market Share Forecast by Region (2017-2022)
Table EMEA Oncology Adjuvants Revenue (Million USD) Forecast by Region (2017-2022)
Figure EMEA Oncology Adjuvants Revenue Market Share Forecast by Region (2017-2022)
Table Europe Oncology Adjuvants Sales (K Units) Forecast by Countries (2017-2022)
Figure Europe Oncology Adjuvants Sales Market Share Forecast by Countries (2017-2022)
Table Europe Oncology Adjuvants Revenue (Million USD) Forecast by Countries (2017-2022)
Figure Europe Oncology Adjuvants Revenue Market Share Forecast by Countries (2017-2022)
Table Middle East Oncology Adjuvants Sales (K Units) Forecast by Countries (2017-2022)
Figure Middle East Oncology Adjuvants Sales Market Share Forecast by Countries (2017-2022)
Table Middle East Oncology Adjuvants Revenue (Million USD) Forecast by Countries (2017-2022)
Figure Middle East Oncology Adjuvants Revenue Market Share Forecast by Countries (2017-2022)
Table Africa Oncology Adjuvants Sales (K Units) Forecast by Countries (2017-2022)
Figure Africa Oncology Adjuvants Sales Market Share Forecast by Countries (2017-2022)
Table Africa Oncology Adjuvants Revenue (Million USD) Forecast by Countries (2017-2022)
Figure Africa Oncology Adjuvants Revenue Market Share Forecast by Countries (2017-2022)
Table EMEA Oncology Adjuvants Sales (K Units) Forecast by Type (2017-2022)
Figure EMEA Oncology Adjuvants Sales Market Share Forecast by Type (2017-2022)
Table EMEA Oncology Adjuvants Sales (K Units) Forecast by Application (2017-2022)
Figure EMEA Oncology Adjuvants Sales Market Share Forecast by Application (2017-2022)
Table Research Programs/Design for This Report
Figure Bottom-up and Top-down Approaches for This Report
Figure Data Triangulation
Table Key Data Information from Secondary Sources
Table Key Data Information from Primary Sources